- Available history
- No dated observations
- Data captured
IPO Date coverage
CITIUS ONCOLOGY, INC. (CTOR). What the retained company guidance contains and how many periods can be scored.
- Legal name: Value CITIUS ONCOLOGY, INC..
- Ticker: Value CTOR.
- Exchange: Value Nasdaq.
- Shell company merger date: Value 16 Aug 2024.
| Measure | Value |
|---|---|
| Legal name | CITIUS ONCOLOGY, INC. |
| Ticker | CTOR |
| Exchange | Nasdaq |
| Shell company merger date | 16 Aug 2024 |
| Merger completion report | Form 8-K item 5.06 filed 2024-08-16, accession 0001213900-24-070335 |
| Country of operation (business address) | United States |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Business address | 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, New Jersey, 07016, United States |
| Mailing address | 11 COMMERCE DRIVE, FIRST FLOOR, CRANFORD, New Jersey, 07016, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 09-30 |
| Filer category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Common stock, $0.0001 par value · CTOR · NASDAQ 10-Q filed 2026-08-14 cover |
| Shell company | No 10-Q filed 2026-08-14 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-14 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-14 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-14 cover |
| Well-known seasoned issuer | No 10-K filed 2025-12-23 cover |
| Voluntary filer | No 10-K filed 2025-12-23 cover |
| Former names | TenX Keane Acquisition (2021-05-19 to 2024-08-05) |
| First EDGAR filing | 2021-05-19 (S-1) |
| SEC CIK | 1851484 |
| EIN | 994362660 |
| Phone | (908) 967-6677 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |